Authors:
KATZNELSON S
WANG XM
CHIA D
OZAWA M
ZHONG HP
HIRATA M
TERASAKI PI
KOBASHIGAWA JA
Citation: S. Katznelson et al., THE INHIBITORY EFFECTS OF PRAVASTATIN ON NATURAL-KILLER-CELL ACTIVITYIN-VIVO AND ON CYTOTOXIC T-LYMPHOCYTE ACTIVITY IN-VITRO, The Journal of heart and lung transplantation, 17(4), 1998, pp. 335-340
Authors:
ANANDAKUMAR C
ANNAPOORNA V
WONG YC
CHIA D
ARIFF B
RATNAM SS
Citation: C. Anandakumar et al., EARLY FETAL BLOOD-SAMPLING - ANOTHER AVAILABLE OPTION FOR EARLY PRENATAL-DIAGNOSIS, Journal of perinatal medicine, 25(6), 1997, pp. 505-508
Authors:
ANANDAKUMAR C
CHEW S
WONG YC
CHIA D
RATNAM SS
Citation: C. Anandakumar et al., ROLE OF TRANSVAGINAL ULTRASOUND COLOR-FLOW IMAGING AND DOPPLER WAVE-FORM ANALYSIS IN DIFFERENTIATING BETWEEN BENIGN AND MALIGNANT OVARIAN-TUMORS, Ultrasound in obstetrics & gynecology, 7(4), 1996, pp. 280-284
Authors:
KATZNELSON S
WILKINSON AH
KOBASHIGAWA JA
WANG XM
CHIA D
OZAWA M
ZHONG HP
HIRATA M
COHEN AH
TERASAKI PI
DANOVITCH GM
Citation: S. Katznelson et al., THE EFFECT OF PRAVASTATIN ON ACUTE REJECTION AFTER KIDNEY-TRANSPLANTATION - A PILOT-STUDY, Transplantation, 61(10), 1996, pp. 1469-1474
Authors:
ANANDAKUMAR C
BISWAS A
CHEW SSL
CHIA D
WONG YC
RATNAM SS
Citation: C. Anandakumar et al., DIRECT FETAL THERAPY FOR HYDROPS SECONDARY TO CONGENITAL ATRIOVENTRICULAR HEART-BLOCK, Obstetrics and gynecology, 87(5), 1996, pp. 835-837
Authors:
KOBASHIGAWA JA
KATZNELSON S
LAKS H
JOHNSON JA
YEATMAN L
WANG XM
CHIA D
TERASAKI PI
SABAD A
COGERT GA
TROSIAN K
HAMILTON MA
MORIGUCHI JD
KAWATA N
HAGE A
DRINKWATER DC
STEVENSON LW
Citation: Ja. Kobashigawa et al., EFFECT OF PRAVASTATIN ON OUTCOMES AFTER CARDIAC TRANSPLANTATION, The New England journal of medicine, 333(10), 1995, pp. 621-627
Authors:
KATZNELSON S
WILKINSON AH
DANOVITCH GM
WANG XM
CHIA D
KOBASHIGAWA JA
ZHONG HP
OZAWA M
TERASAKI PI
Citation: S. Katznelson et al., PRAVASTATIN LOWERS NATURAL-KILLER-CELL CYTOTOXICITY AND DECREASES THEINCIDENCE OF EARLY ACUTE REJECTION EPISODES IN RENAL-TRANSPLANT PATIENTS, Journal of the American Society of Nephrology, 5(3), 1994, pp. 1017-1017
Authors:
KATZNELSON S
KOBASHIGAWA JA
WANG XM
CHIA D
ZHONG HP
OZAWA M
GLEESON MP
MORIGUCHI JD
LAKS H
TERASAKI PI
Citation: S. Katznelson et al., PRAVASTATIN USE IN HEART-TRANSPLANT PATIENTS SUPPRESSES NATURAL-KILLER-CELL (NKC) CYTOTOXICITY AND MAY BE ASSOCIATED WITH REDUCED ALLOGRAFT-REJECTION, Circulation, 90(4), 1994, pp. 200-200
Authors:
KATZNELSON S
KOBASHIGAWA JA
WANG XM
CHIA D
ZHONG HP
OZAWA M
GLEESON MP
MORIGUCHI JD
LAKS H
TERASAKI PI
Citation: S. Katznelson et al., PRAVASTATIN USE IN HEART-TRANSPLANT PATIENTS SUPPRESSES NATURAL-KILLER-CELL (NKC) CYTOTOXICITY AND MAY BE ASSOCIATED WITH REDUCED ALLOGRAFT-REJECTION, Circulation, 90(4), 1994, pp. 200-200
Authors:
CHIA D
TERASAKI PI
CHAN H
TONAI R
SIAUW PA
Citation: D. Chia et al., DIRECT-DETECTION OF PCR PRODUCTS BY SEQUENCE-SPECIFIC PRIMER FOR HLA CLASS-II TYPING, Human immunology, 37, 1993, pp. 135-135
Authors:
LIM EC
CHIA D
GJERTSON DW
KOKA P
TERASAKI PI
Citation: Ec. Lim et al., INVITRO STUDIES TO EXPLAIN HIGH RENAL-ALLOGRAFT SURVIVAL IN IGA NEPHROPATHY PATIENTS, Transplantation, 55(5), 1993, pp. 996-999
Authors:
ANANDAKUMAR C
ANNAPOORNA V
CHEE WY
CHIA D
BONGSO A
RATNAM SS
Citation: C. Anandakumar et al., FETAL BLOOD-SAMPLING AND ITS COMPLICATIONS RELATED TO THE INDICATIONSFOR FETAL BLOOD-SAMPLING, Australian and New Zealand Journal of Obstetrics and Gynaecology, 33(3), 1993, pp. 259-261